OTCs NCPA
Latest
Retail spending shows resilience
The sector benefited from an unusual convergence of spending opportunities in June.
Biosimilars Council and AAM endorse House bill to streamline biosimilar development
The Expedited Access to Biosimilars Act would codify the FDA's science-based approach to biosimilar review by limiting comparative efficacy studies.
Beauty at Walmart gets makeover
Shoppers can currently find Beauty 2.0 in some 150 Walmart stores, with 300 more conversions expected by the end of 2026.
Expect B-T-S shoppers to favor stores
The takeaway for retailers isn’t to shout louder about price. It’s to prove, aisle by aisle, that being in-store still delivers what shoppers need, when they need it.